Read our guide on Gamma Knife radiosurgery for brain metastases, exploring how it preserves cognitive function and compares to whole-brain radiation
Gamma Knife Radiosurgery delivered by Amethyst Radiotherapy provides highly specialised stereotactic radiosurgery and brain metastases treatment for patients with brain metastases, primary brain tumours, vascular malformations, and other intracranial conditions. Treatment is available at the National Hospital for Neurology and Neurosurgery in Queen Square, London, and at Thornbury Hospital, providing access to dedicated Gamma Knife technology within specialist neurosurgical environments. Modern Gamma Knife radiosurgery protocols enable highly targeted radiation delivery to intracranial lesions while minimising radiation exposure to surrounding healthy brain tissue. For appropriately selected patients requiring brain metastases treatment, Gamma Knife offers an established alternative to Whole-Brain Radiation Therapy (WBRT), supporting effective local tumour control and fewer/more tolerable side effects through advanced radiosurgery protocols and personalised treatment planning.
Amethyst Radiotherapy delivers Gamma Knife Radiosurgery from two established UK centres: the National Hospital for Neurology and Neurosurgery, Queen Square, London, and Thornbury Hospital, Sheffield. Both centres provide access to dedicated Gamma Knife services, evidence-based radiosurgery protocols, and multidisciplinary expertise for patients requiring brain metastases treatment and management of other complex intracranial conditions.
Gamma Knife Radiosurgery delivered by Amethyst Radiotherapy is provided within dedicated neurosurgical services by highly specialised teams with extensive experience in Gamma Knife treatment, stereotactic radiosurgery, and intracranial radiosurgery protocols. Patients benefit from expert management of complex neurological conditions supported by specialist neuroradiology, neuro-oncology expertise, and multidisciplinary clinical review.
The use of established radiosurgery protocols allows highly personalised treatment planning for patients with brain metastases, primary brain tumours, vestibular schwannomas, meningiomas, arteriovenous malformations, trigeminal neuralgia, and other conditions requiring Gamma Knife treatment.
The principal difference between Gamma Knife Radiosurgery and Whole-Brain Radiation Therapy lies in the volume of tissue treated and the radiosurgery protocols used to deliver treatment.
Gamma Knife brain metastases treatment focuses radiation only on identified intracranial targets. Advanced Gamma Knife radiosurgery protocols allow radiation to conform closely to the shape and size of each lesion, enabling effective treatment while minimising exposure to surrounding healthy brain tissue.
By contrast, Whole-Brain Radiation Therapy delivers radiation to the entire brain and is intended to treat both visible disease and potential microscopic disease. While WBRT remains an important treatment option in selected clinical situations, it exposes larger volumes of healthy brain tissue to radiation compared with targeted Gamma Knife radiosurgery protocols.
Gamma Knife employs 192 cobalt-60 radiation sources that converge precisely on the treatment target. These advanced radiosurgery protocols create an exceptionally steep dose gradient, meaning radiation levels decrease rapidly outside the intended treatment area.
This precision allows Gamma Knife brain metastases treatment to minimise radiation exposure to healthy brain tissue while maintaining effective dose delivery to intracranial lesions. Gamma Knife radiosurgery protocols are particularly valuable when treating lesions located close to critical neurological structures, including the brainstem, optic nerves, optic chiasm, cochlea and cranial nerves.
Preservation of cognitive function is increasingly important for patients undergoing brain metastases treatment, particularly as advances in systemic cancer therapies continue to improve overall survival.
Because Gamma Knife radiosurgery protocols target only identified lesions, substantially less healthy brain tissue is exposed to radiation in comparison to WBRT. This targeted approach may help preserve memory, attention, executive function and overall neurocognitive performance in appropriately selected patients undergoing Gamma Knife treatment.
Gamma Knife is purpose-built for intracranial stereotactic radiosurgery and is recognised internationally for its high degree of treatment accuracy. Gamma Knife radiosurgery protocols utilise rigid patient immobilisation, advanced imaging, and motion-free treatment delivery to achieve sub-millimetre precision.
These radiosurgery protocols support the treatment of small lesions, recurrent disease, multiple brain metastases, and lesions located adjacent to critical neurological structures. The precision of Gamma Knife treatment contributes to both treatment effectiveness and healthy tissue preservation.
A key component of contemporary Gamma Knife radiosurgery protocols is the use of MRI imaging performed on the day of treatment. Same-day imaging enables treatment planning to reflect the most current representation of tumour anatomy and disease burden.
For patients undergoing brain metastases treatment, this approach supports highly accurate target delineation and allows Gamma Knife treatment plans to be based on up-to-date anatomical information.
Gamma Knife treatment is commonly completed in a single treatment session and is frequently delivered as a day-case procedure. These streamlined radiosurgery protocols may reduce the number of hospital visits required and allow patients to return more quickly to normal daily activities.
Gamma Knife Radiosurgery may be particularly appropriate for:
Contemporary Gamma Knife radiosurgery protocols increasingly focus on overall intracranial disease burden, lesion size, lesion location, patient performance status, and treatment objectives rather than lesion count alone.
Gamma Knife Radiosurgery delivered by Amethyst Radiotherapy is used in the treatment of a wide range of intracranial conditions, including brain metastases, benign and malignant brain tumours, vestibular schwannomas, meningiomas, pituitary tumours, arteriovenous malformations, trigeminal neuralgia, and selected functional neurological disorders.
The combination of dedicated Gamma Knife technology, advanced radiosurgery protocols, specialist neurosurgical expertise, and multidisciplinary care enables highly personalised treatment planning for patients requiring intracranial radiosurgery.
Patients can access Gamma Knife brain metastases treatment delivered by Amethyst Radiotherapy at the National Hospital for Neurology and Neurosurgery in Queen Square, London, and at Thornbury Hospital, Sheffield. Both centres provide access to advanced Gamma Knife radiosurgery protocols, specialist multidisciplinary expertise and dedicated intracranial treatment pathways.
Gamma Knife Radiosurgery and Whole-Brain Radiation Therapy both have established roles in the management of intracranial disease. For appropriately selected patients requiring brain metastases treatment, Gamma Knife offers a highly targeted approach that maximises tumour dose while minimising radiation exposure to healthy brain tissue. Through advanced Gamma Knife radiosurgery protocols, same-day imaging, specialist multidisciplinary assessment, and highly precise treatment delivery, Gamma Knife may support effective local tumour control, healthy tissue preservation, and maintenance of quality of life.
Gamma Knife Radiosurgery delivered by Amethyst Radiotherapy at the National Hospital for Neurology and Neurosurgery, Queen Square, London, and Thornbury Hospital, Sheffield, provides access to specialist brain metastases treatment, advanced intracranial radiosurgery protocols and dedicated neurosurgical expertise for patients across the United Kingdom.
Centres of Excellence for Stereotactic Radiosurgery treatment of complex Brain Tumours
Want to know more about Gamma Knife Treatment?
Our friendly staff are here to help you, get in touch with them today